NCT05079191

Brief Summary

The diagnostic performance of the scanner in the indication of suspected Covid-19 is not yet well known, especially in comparison with the results of RT-PCR. The potential use of the scanner as a tool for quantifying the severity of Covid-19 disease is not yet well established, especially the variations between readers or between measurement techniques. The impact of the scanner in predicting the fate of patients with confirmed Covid-19 is not yet known.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
2,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2020

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2020

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

October 14, 2021

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 15, 2021

Completed
17 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2021

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2021

Completed
Last Updated

November 3, 2021

Status Verified

October 1, 2021

Enrollment Period

1.4 years

First QC Date

October 14, 2021

Last Update Submit

October 26, 2021

Conditions

Keywords

COVID-19SARS-COV-2Chest scannerCT scanRT-PCR

Outcome Measures

Primary Outcomes (1)

  • Retrospective study of the chest scanner in suspected Covid-19

    Files analysed retrospectively from March 01, 2020 to April 29, 2020 will be examined]

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patient admitted to Strasbourg University Hospitals for suspicion of Covid-19

You may qualify if:

  • Adult patient (≥18 years old)
  • Patient admitted to Strasbourg University Hospitals for suspicion of Covid-19, between 03/01/2020 and 04/29/2020
  • Availability of at least one chest CT scan during hospitalization
  • Subject not having expressed his opposition, after information, to the reuse of his data for the purposes of this research.
  • Patient who expressed his opposition to participating in the study
  • Patient under legal protection
  • Patient under guardianship or guardianship

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Service de Radiologie B - Hôpitaux Universitaires de Strasbourg

Strasbourg, 67091, France

RECRUITING

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Central Study Contacts

Saïd CHAYER, PhD, HDR

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 14, 2021

First Posted

October 15, 2021

Study Start

June 1, 2020

Primary Completion

November 1, 2021

Study Completion

November 30, 2021

Last Updated

November 3, 2021

Record last verified: 2021-10

Locations